Xencor
XNCRAlgoritmens signaler
- ›Starkt 3m-momentum (+53.7%)
- ›Starkt 6m-momentum (+135.0%)
- ›Starkt 12m-momentum (+113.9%)
- ›Pris över MA50 och MA200 (uppåttrend)
- ›Hög volatilitet (62% årlig)
- ›+187% från 52v-botten
- ›Ökad handelsvolym (+24%)
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsVanguard updates its passive Xencor (XNCR) stake, with voting power over 507,754 shares. - Stock Titan
1 d sedanVanguard updates its passive Xencor (XNCR) stake, with voting power over 507,754 shares. Stock Titan
Stock TitanXencor, Inc. $XNCR Shares Newly Bought by VestGen Advisors LLC - MarketBeat
2 d sedanXencor, Inc. $XNCR Shares Newly Bought by VestGen Advisors LLC MarketBeat
MarketBeatCanaccord Genuity Keeps Their Buy Rating on Xencor (XNCR) - The Globe and Mail
3 d sedanCanaccord Genuity Keeps Their Buy Rating on Xencor (XNCR) The Globe and Mail
The Globe and MailXencor, Inc. (XNCR) Stock Forecasts - Yahoo Finance
4 d sedanXencor, Inc. (XNCR) Stock Forecasts Yahoo Finance
Yahoo FinanceXencor soars 16% on encouraging early XmAb819 data (XNCR:NASDAQ) - Seeking Alpha
5 d sedanXencor soars 16% on encouraging early XmAb819 data (XNCR:NASDAQ) Seeking Alpha
Seeking AlphaXencor Catapults On 'Unprecedented,' 'Profound' Cancer Data - Investor's Business Daily
5 d sedanXencor Catapults On 'Unprecedented,' 'Profound' Cancer Data Investor's Business Daily
Investor's Business DailyWhy Is Xencor Stock Trading Higher Today? - Xencor (NASDAQ:XNCR) - Benzinga
5 d sedanWhy Is Xencor Stock Trading Higher Today? - Xencor (NASDAQ:XNCR) Benzinga
BenzingaIs Xencor (XNCR) A Bargain After Its XmAb819 Phase 1 Update? - Yahoo Finance
2026-10-19Is Xencor (XNCR) A Bargain After Its XmAb819 Phase 1 Update? Yahoo Finance
Yahoo FinanceXencor Reports Second Quarter 2026 Financial Results
2026-08-05Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the se
XencorBusiness WireXencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter
2026-07-29Xencor, Inc. (NASDAQ:XNCR) (“Xencor”), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced its agreement wi
XencorBusiness WireXencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
2026-07-17Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that results from a Phase 1
XencorBusiness WireXencor Reports First Quarter 2026 Financial Results
2026-05-06Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the fi
XencorBusiness WireXencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW
2026-05-04Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported final results from the Phase
XencorBusiness WireXencor Announces Change to Ultomiris® Royalty Revenue Forecast
2026-03-04Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that Alexion Pharmaceutical
XencorBusiness WireXencor Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-25Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the fo
XencorBusiness WireXencor to Participate at Upcoming Investor Conferences
2026-02-23Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that company management wil
XencorBusiness Wire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.